Nicolas Serranio

Disclosure information not submitted.

Presentation(s):

• PD11-03: The Use of Phosphodiesterase 5 Inhibitors Is Not Associated with Ocular Adverse Events

  Friday, April 28, 2023
  3:50 PM – 4:00 PM CST